Skip to content

Insider · CIK 0001797672

Karen Akinsanya

presidentofficerdirector

Files at SDGR (Schrodinger, Inc.), NAUT (Nautilus Biotechnology, Inc.). First filing Apr 15, 2025, latest Sep 21, 2026.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $1.4M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

SDGR: Schrodinger, Inc.

SDGROct 9, 2026 · close 27.28

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
14Weak
SDGRsell10b5-1
Schrodinger, Inc.
$928k
31,599 shares
-31%-
3Weak
SDGRsell 210b5-1
Schrodinger, Inc.
$18k
1,366 shares
-2%+16% from low-51% from high
8Weak
SDGRsell 210b5-1
Schrodinger, Inc.
$26k
2,206 shares
-3%+8% from low-54% from high
21Weak
SDGRsell10b5-1
Schrodinger, Inc.
$420k
16,723 shares
-52%+56% from low0% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 17, 2026SDGR
Schrodinger, Inc.
MOption exercise
Common Stock10b5-1
+31,599$4.34$137k101,55521 d ago
Sep 17, 2026SDGR
Schrodinger, Inc.
SOpen-market sale
Common Stock10b5-1
-10,000$28.00$280k91,55521 d ago
Sep 17, 2026SDGR
Schrodinger, Inc.
SOpen-market sale
Common Stock10b5-1
-21,599$30.00$648k69,95621 d ago
Sep 17, 2026SDGR
Schrodinger, Inc.
MOption exercise
Stock Option (right to buy)derivative10b5-1
-31,599$0.00$011,59921 d ago
Mar 5, 2026SDGR
Schrodinger, Inc.
SOpen-market sale
Common Stock10b5-1
-1,366$12.90$18k69,956Mar 6, 2026
Mar 2, 2026SDGR
Schrodinger, Inc.
AGrant or award
Common Stock10b5-1
+24,250$0.00$039,875Mar 3, 2026
Mar 2, 2026SDGR
Schrodinger, Inc.
AGrant or award
Common Stock10b5-1
+6,077$0.00$045,952Mar 3, 2026
Mar 2, 2026SDGR
Schrodinger, Inc.
AGrant or award
Common Stock10b5-1
+27,576$0.00$073,528Mar 3, 2026
Mar 2, 2026SDGR
Schrodinger, Inc.
SOpen-market sale
Common Stock10b5-1
-2,206$11.99$26k71,322Mar 3, 2026
Mar 2, 2026SDGR
Schrodinger, Inc.
AGrant or award
Stock Option (right to buy)derivative10b5-1
+48,500$0.00$048,500Mar 3, 2026
Jun 23, 2025NAUT
Nautilus Biotechnology, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+45,000$0.00$045,000Jun 25, 2025
Apr 14, 2025SDGR
Schrodinger, Inc.
MOption exercise
Common Stock10b5-1
+13,378$3.22$43k29,003Apr 15, 2025
Apr 14, 2025SDGR
Schrodinger, Inc.
MOption exercise
Common Stock10b5-1
+3,345$2.92$9,76732,348Apr 15, 2025
Apr 14, 2025SDGR
Schrodinger, Inc.
SOpen-market sale
Common Stock10b5-1
-8,378$25.11$210k23,970Apr 15, 2025
Apr 14, 2025SDGR
Schrodinger, Inc.
SOpen-market sale
Common Stock10b5-1
-5,000$25.11$126k18,970Apr 15, 2025
Apr 14, 2025SDGR
Schrodinger, Inc.
SOpen-market sale
Common Stock10b5-1
-3,345$25.00$84k15,625Apr 15, 2025
Apr 14, 2025SDGR
Schrodinger, Inc.
MOption exercise
Stock Option (right to buy)derivative10b5-1
-13,378$0.00$00Apr 15, 2025
Apr 14, 2025SDGR
Schrodinger, Inc.
MOption exercise
Stock Option (right to buy)derivative10b5-1
-3,345$0.00$00Apr 15, 2025
Mar 3, 2025SDGR
Schrodinger, Inc.
AGrant or award
Common Stock
+15,625$0.00$015,625Mar 4, 2025
Mar 3, 2025SDGR
Schrodinger, Inc.
AGrant or award
Stock Option (right to buy)derivative
+62,500$0.00$062,500Mar 4, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Karen Akinsanya: insider trades and track record | InsiderTell